Last reviewed · How we verify

High oxygenation target

Aalborg University Hospital · FDA-approved active Small molecule

High oxygenation target is a clinical protocol that increases inspired oxygen levels to maintain elevated blood oxygen saturation in hospitalized patients.

High oxygenation target is a clinical protocol that maintains elevated blood oxygen levels during patient care, rather than a traditional pharmaceutical drug. Used for Clinical protocol for oxygen management in hospitalized patients.

At a glance

Generic nameHigh oxygenation target
Also known asInspired oxygen
SponsorAalborg University Hospital
ModalitySmall molecule
Therapeutic areaCritical Care / Perioperative Medicine
PhaseFDA-approved

Mechanism of action

This is a therapeutic strategy rather than a traditional pharmaceutical drug, involving the administration of supplemental oxygen to achieve and maintain higher arterial oxygen partial pressure (PaO2) and oxygen saturation levels. The approach is based on the hypothesis that increased oxygen availability may improve tissue oxygenation and clinical outcomes in critically ill or acutely ill patients.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: